1. Home
  2. NVVE vs JAGX Comparison

NVVE vs JAGX Comparison

Compare NVVE & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvve Holding Corp.

NVVE

Nuvve Holding Corp.

HOLD

Current Price

$1.17

Market Cap

4.2M

Sector

Energy

ML Signal

HOLD

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$0.63

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVVE
JAGX
Founded
1996
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NVVE
JAGX
Price
$1.17
$0.63
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$60.00
AVG Volume (30 Days)
1.4M
9.3M
Earning Date
03-30-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,630,156.00
$11,785,000.00
Revenue This Year
$892.33
$22.41
Revenue Next Year
N/A
$30.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.45
52 Week Low
$1.14
$0.56
52 Week High
$200.80
$25.75

Technical Indicators

Market Signals
Indicator
NVVE
JAGX
Relative Strength Index (RSI) 35.49 42.22
Support Level $1.14 $0.56
Resistance Level $1.42 $0.69
Average True Range (ATR) 0.24 0.06
MACD -0.09 0.01
Stochastic Oscillator 2.26 42.23

Price Performance

Historical Comparison
NVVE
JAGX

About NVVE Nuvve Holding Corp.

Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: